Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial. De Ferrari GM, Giugliano RP, Leiter LA, Nicolau JC, et al. Eur Heart J 2026 Aug 28:ehag739. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

De Ferrari GM, Giugliano RP, Leiter LA, Nicolau JC, et al. Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial. Eur Heart J 2026 Aug 28:ehag739. doi: 10.1093.
PMID: 42663056